Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8026506rdf:typepubmed:Citationlld:pubmed
pubmed-article:8026506lifeskim:mentionsumls-concept:C1135183lld:lifeskim
pubmed-article:8026506lifeskim:mentionsumls-concept:C0242692lld:lifeskim
pubmed-article:8026506lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:8026506pubmed:issue3lld:pubmed
pubmed-article:8026506pubmed:dateCreated1994-8-11lld:pubmed
pubmed-article:8026506pubmed:abstractTextIn soluble and particulate extracts from muscle D-myo-inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] and D-myo-inositol 1,3,4,5-tetrakisphosphate [Ins(1,3,4,5)P4] are metabolised stepwise to inositol. Ins(1,4,5)P3 is rapidly dephosphorylated to D-myo-inositol 1,4-bisphosphate then to D-myo-inositol 4-phosphate and finally inositol. In soluble extracts Ins(1,3,4,5)P4 is dephosphorylated to D-myo-inositol 1,3,4-trisphosphate then sequentially to D-myo-inositol 3,4-bisphosphate, D-myo-inositol 3-phosphate and inositol, while in particulate extracts D-myo-inositol 1,3-bisphosphate is the predominant inositol bisphosphate formed. Dephosphorylation of these inositol polyphosphates is Mg2+ dependent and inhibited by D-2,3-bisphosphoglyceric acid. Ins(1,4,5)P3 is also phosphorylated to form Ins(1,3,4,5)P4 in soluble extracts by Ins(1,4,5)P3 3-kinase. Ins(1,4,5)P3 3-kinase activity is Mg2+ and ATP dependent and is stimulated by Ca2+ and calmodulin. Particulate (sarcotubular) inositol polyphosphate 5-phosphatase (5-phosphatase) is found in membranes which are intimately involved in excitation-contraction coupling and the generation of the primary Ca2+ signal of muscle cells. Particulate 5-phosphatase had the highest specific activity in the transverse-tubule membrane, when compared to the terminal cisternae and longitudinal-tubule membranes of the sarcoplasmic reticulum. Particulate Ins(1,3,4,5)P4-3-phosphatase activity was also detected after fractionation of solubilised sarcotubular membranes by DEAE-Sephacel. Particulate 5-phosphatase activity was purified 25,600-fold to a specific activity of 25.6 mumol Ins(1,4,5)P3 hydrolysed.min-1.mg protein-1, after DEAE-Sephacel and novel affinity chromatography using D-2,3-bisphosphoglycerate/agarose and Sepharose-4B-immobilised Ins(1,4,5)P3-analog matrices. Purified particulate 5-phosphatase had apparent Km of 46.3 microM and 1.9 microM and Vmax of 115 and 0.046 mumol substrate hydrolysed.min-1.mg protein-1, for Ins(1,4,5)P3 and Ins(1,3,4,5)P4, respectively. In contrast, purified soluble type I 5-phosphatase had apparent Km of 8.9 microM and 1.1 microM and Vmax of 3.55 and 0.13 mumol substrate hydrolysed.min-1.mg protein-1, for Ins(1,4,5P3 and Ins(1,3,4,5)P4, respectively. As in other cells, muscle 5-phosphatases have a lower affinity, but a higher capacity to metabolise Ins(1,4,5)P3 than Ins(1,3,4,5)P4. Soluble type I 5-phosphatase may have a functional role in the metabolism of both inositol polyphosphates, while particulate 5-phosphatase may primarily metabolise Ins(1,4,5)P3. Purified Ins(1,4,5)P3 3-kinase had an apparent Km of 0.42 microM and a Vmax of 4.12 nmol Ins(1,4,5)P3 phosphorylated.min-1.mg protein-1. The profile of inositol polyphosphate metabolism in muscle is similar to that reported in other tissues.(ABSTRACT TRUNCATED AT 400 WORDS)lld:pubmed
pubmed-article:8026506pubmed:languageenglld:pubmed
pubmed-article:8026506pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8026506pubmed:citationSubsetIMlld:pubmed
pubmed-article:8026506pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8026506pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8026506pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8026506pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8026506pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8026506pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8026506pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8026506pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8026506pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8026506pubmed:statusMEDLINElld:pubmed
pubmed-article:8026506pubmed:monthJunlld:pubmed
pubmed-article:8026506pubmed:issn0014-2956lld:pubmed
pubmed-article:8026506pubmed:authorpubmed-author:O'BrienRRlld:pubmed
pubmed-article:8026506pubmed:authorpubmed-author:DenboroughM...lld:pubmed
pubmed-article:8026506pubmed:authorpubmed-author:OzakiSSlld:pubmed
pubmed-article:8026506pubmed:authorpubmed-author:PotterB VBVlld:pubmed
pubmed-article:8026506pubmed:authorpubmed-author:HansbroP MPMlld:pubmed
pubmed-article:8026506pubmed:authorpubmed-author:FosterP SPSlld:pubmed
pubmed-article:8026506pubmed:authorpubmed-author:HoganS PSPlld:pubmed
pubmed-article:8026506pubmed:issnTypePrintlld:pubmed
pubmed-article:8026506pubmed:day15lld:pubmed
pubmed-article:8026506pubmed:volume222lld:pubmed
pubmed-article:8026506pubmed:ownerNLMlld:pubmed
pubmed-article:8026506pubmed:authorsCompleteYlld:pubmed
pubmed-article:8026506pubmed:pagination955-64lld:pubmed
pubmed-article:8026506pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:meshHeadingpubmed-meshheading:8026506-...lld:pubmed
pubmed-article:8026506pubmed:year1994lld:pubmed
pubmed-article:8026506pubmed:articleTitleThe metabolism of D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle.lld:pubmed
pubmed-article:8026506pubmed:affiliationDivision of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra.lld:pubmed
pubmed-article:8026506pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8026506pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8026506lld:pubmed